Octapharma, one of the largest independent manufacturers of human protein products worldwide, has added the PAS-X Track & Trace Serialisation Aggregation solution to Werum's PAS-X at their production site in Vienna.
Octapharma has been committed to patient care and medical developments for over 30 years. Its core business is the development, production and sale of human proteins from human plasma and human cell-lines. Patients in over 100 countries are treated with products in the areas of haematology, immunotherapy and critical care. Octapharma owns five production facilities in Austria, France, Germany, Sweden and Mexico.
Octapharma employs strict in-process quality control systems to ensure traceability, providing the complete documentation of the origin of all plasma donations, their processing and distribution to countries worldwide. The company requires a flexible and stringently validated system for marking, identifying and tracking their products.
In a first step, PAS-X Track & Trace will be operated in the packaging area for the Chinese market. The serialisation data provided by the Chinese authorities are loaded and the used data are reported back. PAS-X Track & Trace is interfaced to the existing PAS-X and exchanges order and stock data with the MES.
It is intended to install Werum's PAS-X Track & Trace at further packaging lines for different target countries in the Vienna site.